Despite the well-accepted role of the two main neuropathological markers (β-amyloid and tau) in the progression of Alzheimer’s disease, the interaction and specific contribution of each of them is not fully elucidated. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.